Genky DrugStores Co., Ltd.

Equities

9267

JP3282750003

Drug Retailers

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
5,790 JPY -5.70% Intraday chart for Genky DrugStores Co., Ltd. -4.14% +6.04%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended March 2024 CI
Genky DrugStores Co., Ltd. Provides Dividend Guidance for Year Ending June 20, 2024 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024 CI
Genky Drugstores Co., Ltd. Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024 CI
Genky DrugStores’s Attributable Net Income Up 7.8% to 4.76 Billion Yen in Fiscal 2022; Shares Rise 8% MT
Genky Drugstores Co., Ltd. Announces Dividend for the Year Ended June 20, 2023, Payable on September 8, 2023; Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024 CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2024 CI
Genky DrugStores Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Announces Dividend for the Second Quarter Ended December 20, 2022, Payable on February 27, 2023; Provides Dividend Guidance for the Fiscal Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Provides Second Quarter End and Year End Dividend Guidance for the Fiscal 2022 CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023 CI
Genky DrugStores Co., Ltd. Provides Dividend Guidance for the Fiscal 2021 CI
Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2022 CI
Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending June 30, 2022 CI
Genky Drugstores Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending June 20, 2022 and Full Year Ending June 20, 2022 CI
Genky Drugstores Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended June 20, 2021 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year June 20, 2022 CI
Genky DrugStores Co., Ltd. Declares Dividend for the Year Ended June 20, 2021, Payable from September 6, 2021; Provides Dividend Guidance for the Second Quarter of 2022 and Fiscal Year 2022 CI
Genky Drugstores Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended March 20, 2021 CI
Genky DrugStores Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended December 20, 2020 CI
Genky DrugStores Co., Ltd. Provides Consolidated Earnings Forecast for the Fiscal Year Ending June 20, 2021 CI
Chart Genky DrugStores Co., Ltd.
More charts
Genky DrugStores Co Ltd is mainly engaged in the management of group companies and the related business. The Company is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5,790 JPY
Average target price
7,600 JPY
Spread / Average Target
+31.26%
Consensus
  1. Stock Market
  2. Equities
  3. 9267 Stock
  4. News Genky DrugStores Co., Ltd.
  5. Genky DrugStores’s Attributable Net Income Up 7.8% to 4.76 Billion Yen in Fiscal 2022; Shares Rise 8%